Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.77
-1.13 (-14.30%)
At close: Mar 31, 2025, 4:00 PM
6.30
-0.47 (-6.94%)
Pre-market: Apr 1, 2025, 4:46 AM EDT

Actuate Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-27.29-24.74-20.16
Stock-Based Compensation
20.420.65
Other Operating Activities
2.350.12-0.02
Change in Accounts Payable
-1.51.290.59
Change in Other Net Operating Assets
2.61.281.15
Operating Cash Flow
-21.84-21.63-17.79
Short-Term Debt Issued
5.7--
Total Debt Issued
5.7--
Short-Term Debt Repaid
-0.2--
Total Debt Repaid
-0.2--
Net Debt Issued (Repaid)
5.5--
Issuance of Common Stock
23.96--
Other Financing Activities
-1.93--
Financing Cash Flow
27.534.1319.26
Net Cash Flow
5.68-17.491.46
Levered Free Cash Flow
-12.39-12.64-
Unlevered Free Cash Flow
-12.38-12.61-
Change in Net Working Capital
-1.35-2.57-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q